Drug Master File (DMF) Preparation, Review & Regulatory Support Services – Bulgaria
Bulgarian Drug Agency (BDA)-Compliant DMF Documentation & Regulatory Support
By DMF Direct – A Scientific Arm of Zoesoe Exports Pvt Ltd
DMF Direct provides end-to-end Drug Master File (DMF) preparation, review, submission, and lifecycle management services specifically tailored for Bulgaria’s regulatory framework.
Our DMF services are designed to meet the expectations of the Bulgarian Drug Agency (BDA / ИАЛ – Изпълнителна агенция по лекарствата) and align with:
• Bulgarian Law on Medicinal Products in Human Medicine
• EU GMP (EudraLex, Volume 4)
• ICH Guidelines
• EU-CTD / eCTD-based submissions used for:
• API registration
• Finished pharmaceutical product (FPP) approvals
• Import authorization dossiers
• Export-oriented regulatory filings
We specialize in the preparation and maintenance of both:
Open Part (Applicant’s Part)
Closed Part (Restricted / Confidential Part)
Ensuring full EU-level regulatory compliance, strict confidentiality, and smooth approval processing in Bulgaria.
Our Core DMF Services – Bulgaria
🧪 DMF Preparation – Open & Closed Parts (Bulgaria-Compliant)
We prepare complete, structured, and BDA-aligned DMF dossiers strictly following the EU-CTD format accepted for Bulgarian and EU submissions.
Applicant’s Part (Open Part)
Prepared for submission to BDA / Marketing Authorization Holders (MAH) / EU Applicants, including:
• Quality Overall Summary (QOS) aligned with ICH Q2–Q6
• Non-confidential manufacturing and quality information
• Cross-reference-ready content for:
– EU/Bulgarian Marketing Authorization (MA)
– Import Authorization
– Manufacturing & EU-GMP Certification
• EU-CTD structured documentation suitable for Bulgaria and EU markets
Restricted Part (Closed / Confidential Part)
Secure preparation and handling of proprietary technical information, including:
• Detailed manufacturing process & flow diagrams
• Critical process parameters (CPPs) & in-process controls (IPCs)
• Raw materials, intermediates & finished product specifications
• Analytical methods & method validation (ICH Q2(R2))
• Control strategy & pharmaceutical quality system (PQS)
• Stability data as per EU climatic conditions (Zone II)
✅ Confidential data is disclosed only to BDA/EU regulators and is never shared with applicants or third parties.
DMF Types Covered – Bulgaria
We support EU-CTD-based DMF documentation for:
• Type II – Active Pharmaceutical Ingredients (API), Intermediates
• Type III – Packaging Materials
• Type IV – Excipients
• Type V – Reference / Miscellaneous Information
🧪 DMF Review & Gap Assessment – Bulgaria
Already have a DMF for Bulgaria or the EU?
We conduct a Bulgaria/EU-specific DMF review and regulatory risk assessment based on:
• BDA & EMA expectations and inspection observations
• EU-GMP compliance gaps
• CTD structure and technical content deficiencies
• Manufacturing, validation, and stability inconsistencies
• Likely BDA/EMA deficiency triggers
✔️ You receive a clear, actionable gap assessment report prior to submission or inspection.
🧪 BDA Submission & Bulgaria/EU Regulatory Support
We provide hands-on support for DMF usage and registration filings in Bulgaria and across the EU, including:
• BDA submissions and regulatory clarifications
• API registration & CEP-linked DMF support
• Import authorization dossiers
• EU-GMP & manufacturing documentation
• Export-linked DMF alignment
Our team ensures:
• Correct EU-CTD / eCTD formatting
• Accurate cross-referencing
• Full consistency across DMF, MA dossier, and manufacturing records
🧪 DMF Lifecycle Management & Maintenance – Bulgaria
We manage your DMF throughout its complete regulatory lifecycle in Bulgaria and the EU, including:
• Initial DMF compilation
• Annual updates, variations & renewals
• Manufacturing site changes
• Process optimization or scale-up documentation
• Stability updates (real-time & accelerated)
• Specification & analytical method revisions
• BDA/EMA-driven variations and compliance updates
🧪 Post-Submission Deficiency & Query Handling – BDA / EMA
Complete post-submission regulatory support for Bulgaria and the EU, including:
• BDA/EMA deficiency letters & technical queries
• Scientific justification & deficiency response drafting
• Revised Open & Closed Part submissions
• Alignment with MAH responses
• Coordination between manufacturer, MAH, BDA & EMA
🎯 Goal: Faster approvals, fewer regulatory queries, and EU-regulator-ready DMF documentation.
🧪 Why Choose DMF Direct for Bulgaria?
🧪 In-depth knowledge of Bulgarian & EU regulatory pathways
🧪 Expertise in EU-GMP, EMA & ICH-aligned DMF documentation
🧪 Secure handling of confidential manufacturing data (GDPR-compliant)
🧪 Strong BDA/EMA deficiency response experience
🧪 Seamless coordination with Bulgarian & EU Marketing Authorization Holders
🧪 Backed by Zoesoe Exports Pvt Ltd’s global regulatory strength
Industries We Support – Bulgaria
• API manufacturers
• Finished formulation manufacturers (FPP)
• Excipient manufacturers
• Packaging material suppliers
• Importers & exporters
• Contract manufacturing organizations (CMOs)
Regulatory Standards Followed – Bulgaria
• Bulgarian Law on Medicinal Products in Human Medicine
• Bulgarian Drug Agency (BDA) Guidelines
• EU GMP – EudraLex Volume 4
• ICH Q-Series & M-Series Guidelines
• EU-CTD / eCTD-ready documentation
• EMA, EDQM & WHO Technical Reports
Your Trusted Partner for DMF Excellence in Bulgaria
Whether you are preparing a new DMF, updating an existing dossier, supporting a BDA/EMA submission, or responding to regulatory queries, DMF Direct delivers high-quality, compliant, and approval-focused DMF solutions for the Bulgarian and EU pharmaceutical markets.
✅ Regulatory-aligned
✅ Confidential
✅ Efficient
✅ Approval-driven